Clinical Trial Update: Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating orteronel plus prednisone in chemotherapy-naive metastatic castration-resistant prostate cancer has completed and posted results. The u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Orteronel (Orteronel)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-05-17